Electronic Journal of General Medicine

• Morita H, Yoshimura A. Glomerulonephritis in sarcoidosis. Clin Exp Nephrol 2006;10:85-6.
• Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999;160:736-55.
• Mohan A, Sood R, Shariff N, Gulati MS, Gupta SD, Dutta AK. Sarcoidosis manifesting as massive splenomegaly: a rare occurrence. Am J Med Sci 2004; 328: 170-2.
• Kawano S, Kato J, Kawano N, et al. Sarcoidosis manifesting as cardiac sarcoidosis and massive splenomegali. Intern Med 2012;51: 65-9
• Kruithoff KL, Gyetko MR, Scheiman JM. Giant splenomegaly and refractory hypercalcemia due to extrapulmonary sarcoidosis. Successful treatment by splenectomy. Arch Intern Med 1993;153:2793-6.
• Bergner R, Hoffmann M, Waldherr R, Uppenkamp M. Frequency of kidney disease in chronic sarcoidosis. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:126-32.
• Taylor JE, Ansell ID. Steroid-sensitive nephrotic syndrome and renal impairment in a patient with sarcoidosis and IgA nephropathy. Nephrol Dial Transplant 1996;11:355-6.
• Hsu SI, Ramirez SB, Winn MP, Bonventre VJ, Owen WE. Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int 2000;57:1818–35.
• Rybicki BA, Iannuzzi MC, Frederick MM, et al; ACCESS Research Group. Familial aggregation of sarcoidosis. A case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001;164:2085-91.
• Xie J, Kiryluk K, Wang W, et al. Predicting progression of IgA nephropathy: new clinical progression risk score. PLoS One. 2012;7(6):e38904. Epub 2012 Jun 14.
• Hamada K, Nagai S, Ono T, et al. Sarcoisosis complicated with IgA nephropathy. Sarcoidosis Vasc Diffuse Lung Dis 2003;20:69–73.

Vancouver

Elcioglu OC, Ozkok A, Bakan A, Ozluk Y, Kilicaslan I, Ak A, et al. IgA Nephropathy in the Course of Sarcoidosis with Multi-Systemic Involvement. EUR J GEN MED. 2015;12(2):167-9. https://doi.org/10.15197/sabad.1.12.34

APA

Elcioglu, O. C., Ozkok, A., Bakan, A., Ozluk, Y., Kilicaslan, I., Ak, A., Donmez, G. E., & Odabas, A. R. (2015). IgA Nephropathy in the Course of Sarcoidosis with Multi-Systemic Involvement. European Journal of General Medicine, 12(2), 167-169. https://doi.org/10.15197/sabad.1.12.34

AMA

Elcioglu OC, Ozkok A, Bakan A, et al. IgA Nephropathy in the Course of Sarcoidosis with Multi-Systemic Involvement. EUR J GEN MED. 2015;12(2), 167-169. https://doi.org/10.15197/sabad.1.12.34

Chicago

Elcioglu, Omer Celal, Abdullah Ozkok, Ali Bakan, Yasemin Ozluk, Isin Kilicaslan, Aslihan Ak, Gul Erdal Donmez, and Ali Riza Odabas. "IgA Nephropathy in the Course of Sarcoidosis with Multi-Systemic Involvement". European Journal of General Medicine 2015 12 no. 2 (2015): 167-169. https://doi.org/10.15197/sabad.1.12.34

Harvard

Elcioglu, O. C., Ozkok, A., Bakan, A., Ozluk, Y., Kilicaslan, I., Ak, A., . . . Odabas, A. R. (2015). IgA Nephropathy in the Course of Sarcoidosis with Multi-Systemic Involvement. European Journal of General Medicine, 12(2), pp. 167-169. https://doi.org/10.15197/sabad.1.12.34

MLA

Elcioglu, Omer Celal et al. "IgA Nephropathy in the Course of Sarcoidosis with Multi-Systemic Involvement". European Journal of General Medicine, vol. 12, no. 2, 2015, pp. 167-169. https://doi.org/10.15197/sabad.1.12.34